PPTA | Immunoglobulin Literature Database
| New treatment for ITP. |
New treatment for ITP. Wood D. AIDS: A new treatment for HIV-related idiopathic thrombocytopenia purpura (ITP) has been developed. The treatment, WinRho SDTM, is a form of the intravenous immunoglobulin, IVIG. IVIG has been successful at reducing the ability of HIV antibody-fragment clusters to bind to platelets, thus preventing the body from destroying the platelets prematurely. WinRho SD was effective for HIV patients whether they were taking AZT or not. Minor side effects developed following four percent of the infusions. Anemia caused by hemolysis can also be a problem. Suggested dosing is set at 250 IU (50mg/kg bodyweight), and the infusions take about three to five minutes, as opposed to several hours for other IVIG forms. Publication Types:
PMID: 11363105 [PubMed - indexed for MEDLINE] |
